Back to User profile » Dr Stephen I Rennard

Papers published by Dr Stephen I Rennard:


Updated Perspectives on the Role of Biomechanics in COPD: Considerations for the Clinician

Yentes JM, Liu WY, Zhang K, Markvicka E, Rennard SI

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2653-2675

Published Date: 17 October 2022

Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present

Li Y, Dai R, Gwon Y, Rennard SI, Make BJ, Foer D, Strand MJ, Austin E, Young KA, Hokanson JE, Pratte KA, Conway R, Kinney GL

Clinical Epidemiology 2022, 14:731-735

Published Date: 1 June 2022

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)

Zou C, Li F, Choi J, Haghighi B, Choi S, Rajaraman PK, Comellas AP, Newell Jnr JD, Lee CH, Barr RG, Bleecker E, Cooper CB, Couper D, Han M, Hansel NN, Kanner RE, Kazerooni EA, Kleerup EC, Martinez FJ, O'Neal W, Paine III R, Rennard SI, Smith BM, Woodruff PG, Hoffman EA, Lin CL

International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1477-1496

Published Date: 31 May 2021

Co-Morbidity Patterns Identified Using Latent Class Analysis of Medications Predict All-Cause Mortality Independent of Other Known Risk Factors: The COPDGene® Study

Li Y, Ragland M, Austin E, Young K, Pratte K, Hokanson JE, Beaty TH, Regan EA, Rennard SI, Wern C, Jacobs MR, Tal-Singer R, Make BJ, Kinney GL

Clinical Epidemiology 2020, 12:1171-1181

Published Date: 27 October 2020

Can CAPTURE be used to identify undiagnosed patients with mild-to-moderate COPD likely to benefit from treatment?

Leidy NK, Martinez FJ, Malley KG, Mannino DM, Han MLK, Bacci ED, Brown RW, Houfek JF, Labaki WW, Make BJ, Meldrum CA, Quezada W, Rennard S, Thomashow B, Yawn BP

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1901-1912

Published Date: 13 June 2018

Use of a 4-week up-titration regimen of roflumilast in patients with severe COPD

Watz H, Bagul N, Rabe KF, Rennard S, Alagappan VKT, Román J, Facius A, Calverley PMA

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:813-822

Published Date: 6 March 2018

Interpreting patient-reported outcomes from clinical trials in COPD: a discussion

Jones PW, Rennard S, Tabberer M, Riley JH, Vahdati-Bolouri M, Barnes NC

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3069-3078

Published Date: 7 December 2016

Influence of diet and obesity on COPD development and outcomes

Hanson C, Rutten EP, Wouters EFM, Rennard S

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:723-733

Published Date: 5 August 2014

Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials

Rennard SI, Sun SX, Tourkodimitris S, Rowe P, Goehring UM, Bredenbröker D, Calverley PM

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:657-673

Published Date: 24 June 2014

Anti-inflammatory effects of budesonide in human lung fibroblasts are independent of histone deacetylase 2

Wang X, Nelson A, Weiler ZM, Patil A, Sato T, Kanaji N, Nakanishi M, Michalski J, Farid M, Basma H, LeVan TD, Miller-Larsson A, Wieslander E, Muller KC, Holz O, Magnussen H, Rabe KF, Liu X, Rennard SI

Journal of Inflammation Research 2013, 6:109-119

Published Date: 20 August 2013

Effect of budesonide on fibroblast-mediated collagen gel contraction and degradation

Fang Q, Schulte NA, Kim H, Kobayashi T, Wang X, Miller-Larsson A, Wieslander E, Toews ML, Liu X, Rennard SI

Journal of Inflammation Research 2013, 6:25-33

Published Date: 27 February 2013

Inflammatory cytokines regulate endothelial cell survival and tissue repair functions via NF-κB signaling

Kanaji N, Sato T, Nelson A, Wang X, Li Y, Kim M, Nakanishi M, Basma H, Michalski J, Farid M, Chandler M, Pease W, Patil A, Rennard SI, Liu X

Journal of Inflammation Research 2011, 4:127-138

Published Date: 15 September 2011